Tilray Brands (NASDAQ:TLRY – Get Free Report) and Trulieve Cannabis (NYSE:TRLV – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, profitability, dividends and risk.
Insider & Institutional Ownership
9.3% of Tilray Brands shares are owned by institutional investors. 1.6% of Tilray Brands shares are owned by insiders. Comparatively, 3.8% of Trulieve Cannabis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Tilray Brands and Trulieve Cannabis’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Tilray Brands | -16.91% | -10.39% | -7.38% |
| Trulieve Cannabis | -41.55% | -4.24% | -1.72% |
Analyst Ratings
This is a summary of current ratings for Tilray Brands and Trulieve Cannabis, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tilray Brands | 2 | 2 | 3 | 1 | 2.38 |
| Trulieve Cannabis | 1 | 1 | 1 | 0 | 2.00 |
Tilray Brands currently has a consensus price target of $5.90, suggesting a potential upside of 83.80%. Trulieve Cannabis has a consensus price target of $15.00, suggesting a potential upside of 45.38%. Given Tilray Brands’ stronger consensus rating and higher possible upside, equities research analysts plainly believe Tilray Brands is more favorable than Trulieve Cannabis.
Valuation and Earnings
This table compares Tilray Brands and Trulieve Cannabis”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tilray Brands | $915.45 million | 0.52 | -$121.40 million | ($1.40) | -2.29 |
| Trulieve Cannabis | $1.18 billion | 1.68 | -$116.38 million | $0.11 | 93.80 |
Trulieve Cannabis has higher revenue and earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Trulieve Cannabis, indicating that it is currently the more affordable of the two stocks.
Summary
Trulieve Cannabis beats Tilray Brands on 7 of the 13 factors compared between the two stocks.
About Tilray Brands
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.
About Trulieve Cannabis
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, and West Virginia, as well as directly to patients through home delivery. It produces approximately 550 stock keeping units, including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. As of May 5, 2021, the company operated through 87 dispensaries in the United States. The company is headquartered in Quincy, Florida.
Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.
